These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7698158)

  • 21. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability.
    Soufer R; Dey HM; Ng CK; Zaret BL
    Am J Cardiol; 1995 Jun; 75(17):1214-9. PubMed ID: 7778542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability.
    Berman DS; Kiat H; Van Train KF; Friedman J; Garcia EV; Maddahi J
    Am J Cardiol; 1990 Oct; 66(13):72E-79E. PubMed ID: 2145750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone scanning in clinical oncology: does it have a future?
    Jacobson AF; Fogelman I
    Eur J Nucl Med; 1998 Sep; 25(9):1219-23. PubMed ID: 9724368
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up.
    Maes AF; Borgers M; Flameng W; Nuyts JL; van de Werf F; Ausma JJ; Sergeant P; Mortelmans LA
    J Am Coll Cardiol; 1997 Jan; 29(1):62-8. PubMed ID: 8996296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic mismatch of septal beta-oxidation and glucose utilization in left bundle branch block assessed with PET.
    Altehoefer C; vom Dahl J; Bares R; Stöcklin GL; Büll U
    J Nucl Med; 1995 Nov; 36(11):2056-9. PubMed ID: 7472598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highlights of the annual meeting of the European Association of Nuclear Medicine: Copenhagen 1996. Nuclear medicine 100 years after the discovery of radioactivity.
    Delaloye AB
    Eur J Nucl Med; 1997 Feb; 24(2):219-32. PubMed ID: 9021123
    [No Abstract]   [Full Text] [Related]  

  • 27. Positron emission tomography in oncology. General acceptance of its role is overdue.
    Lamki LM
    Cancer; 1996 Nov; 78(10):2039-42. PubMed ID: 8918394
    [No Abstract]   [Full Text] [Related]  

  • 28. Tc-99m MIBI scintigraphy in patients with lung cancer. Comparison with CT and fluorine-18 FDG PET imaging.
    Wang H; Maurea S; Mainolfi C; Fiore F; Gravina A; Panico MR; Bazzicalupo L; Salvatore M
    Clin Nucl Med; 1997 Apr; 22(4):243-9. PubMed ID: 9099482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. F-18 FDG accumulation in inflamed joints.
    Yasuda S; Shohtsu A; Ide M; Takagi S; Mitomi T; Suzuki Y
    Clin Nucl Med; 1996 Sep; 21(9):740. PubMed ID: 8879882
    [No Abstract]   [Full Text] [Related]  

  • 30. What is new in nuclear medicine imaging?
    Ferrand SK; Chen CC; Dilsizian V; Neumann RD
    Surg Oncol Clin N Am; 1999 Jan; 8(1):185-204. PubMed ID: 9824368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity and sensitivity of exercise-induced ST segment elevation for detection of residual viability: comparison with fluorodeoxyglucose and positron emission tomography.
    Margonato A; Chierchia SL; Xuereb RG; Xuereb M; Fragasso G; Cappelletti A; Landoni C; Lucignani G; Fazio F
    J Am Coll Cardiol; 1995 Apr; 25(5):1032-8. PubMed ID: 7897113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects.
    Sawada SG; Allman KC; Muzik O; Beanlands RS; Wolfe ER; Gross M; Fig L; Schwaiger M
    J Am Coll Cardiol; 1994 Jan; 23(1):92-8. PubMed ID: 8277101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and economic controversies in radionuclide assessment of myocardial viability.
    Alagona P
    Circulation; 1995 Nov; 92(10):3145-6. PubMed ID: 7586290
    [No Abstract]   [Full Text] [Related]  

  • 34. Emission tomography and cardiac nuclear medicine.
    Maurer AH
    Cardiovasc Clin; 1986; 17(1):145-59. PubMed ID: 3490308
    [No Abstract]   [Full Text] [Related]  

  • 35. Myocardial viability. What does it mean and how do we measure it?
    Gould KL
    Circulation; 1991 Jan; 83(1):333-5. PubMed ID: 1984890
    [No Abstract]   [Full Text] [Related]  

  • 36. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET.
    Altehoefer C; vom Dahl J; Biedermann M; Uebis R; Beilin I; Sheehan F; Hanrath P; Buell U
    J Nucl Med; 1994 Apr; 35(4):569-74. PubMed ID: 8151377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. European Association of Nuclear Medicine procedure guidelines for brain perfusion SPET using (99m)Tc-labelled radiopharmaceuticals.
    Tatsch K; Asenbaum S; Bartenstein P; Catafau A; Halldin C; Pilowsky LS; Pupi A;
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):BP36-42. PubMed ID: 12436497
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease.
    Rossetti C; Landoni C; Lucignani G; Huang G; Bartorelli AL; Guazzi MD; Margonato A; Chierchia S; Galli L; Savi A
    Eur J Nucl Med; 1995 Nov; 22(11):1306-12. PubMed ID: 8575482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of hibernating myocardium: a comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction.
    Mariani MA; Palagi C; Donatelli F; Mengozzi G; Biadi O; Vanoli G; Landoni C; Paolini G; Lucignani G; Fazio F
    Am J Card Imaging; 1995 Jan; 9(1):1-8. PubMed ID: 7894227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Functional brain study by radionuclide neuroimaging].
    Uemura K
    No To Shinkei; 1990 May; 42(5):425-34. PubMed ID: 2206632
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.